ABIOMED, INC.  AND SUBSIDIARIES Notes to Consolidated Financial Statements—(Continued) Note 12.
Stock Award Plans and Stock Based Compensation (Continued) Restricted Stock The following table summarizes restricted stock activity for the fiscal year ended March 31, 2009:
## Table 0 ##
The remaining unrecognized compensation expense for restricted stock awards at March 31, 2009 was $4.6 million.
The weighted average remaining contractual life for restricted stock awards at March 31, 2009 and 2008 was 1.8 and 2.4 years, respectively.
In May 2008, 260,001 shares of restricted stock were issued to certain executive officers and certain members of senior management of the Company, of which 130,002 of these shares vest upon achievement of a prescribed performance milestone.
In September 2008, the Company met the prescribed performance milestone, and all of these performance-based shares vested.
In connection with the vesting of these shares, these employees paid withholding taxes due by returning 39,935 shares valued at $0.7 million.
These shares have been recorded as treasury stock as of March 31, 2009.
The remaining 129,999 of the restricted shares award vest ratably over four years from the grant date.
The stock compensation expense for the restricted stock awards is recognized on a straight-line basis over the vesting period, based on the probability of achieving the performance milestones.
In August 2008, 406,250 shares of restricted stock were issued to certain executive officers and certain members of senior management of the Company, all of which could vest upon achievement of certain prescribed performance milestones.
In March 2009, the Company met a prescribed performance milestone, and a portion of these performance-based shares vested.
The remaining stock compensation expense for the restricted stock awards is being recognized on a straight-line basis over the vesting period through March 31, 2011 based on the probability of achieving the performance milestones.
The cumulative effects of changes in the probability of achieving the milestones will be recorded in the period in which the changes occur.
During the year ended March 31, 2008, 60,000 shares of restricted stock were issued to certain executive officers of the Company that vest on the third anniversary of the date of grant.
The stock compensation expense for the restricted stock awards is recognized on a straight-line basis over the vesting period.
Employee Stock Purchase Plan In March 1988, the Company adopted the 1988 Employee Stock Purchase Plan (“the Purchase Plan” or “ESPP”), as amended.
Under the Purchase Plan, eligible employees, including officers and directors, who have completed three months of employment with the Company or its subsidiaries who elect to participate in the Purchase plan instruct the Company to withhold a specified amount from each payroll period during a six-month payment period (the periods April 1—September 30 and October 1—March 31).
On the last business day of each payment period, the amount withheld is used to purchase common stock at an exercise price equal to 85% of the lower of its market price on the first business day or the last business day of the payment period.
Up to 500,000 shares of common stock may be issued under the Purchase Plan, of which 163,245 shares are available for future issuance as of March 31, 2009.
During the years ended March 31, 2009, 2008 and 2007, 45,823, 23,930, and 27,095 shares of common stock, respectively, were sold pursuant to the Purchase Plan.
PAR T I I Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information Our common stock is traded on the New York Stock Exchange under the ticker symbol BBY.
The table below sets forth the high and low sales prices of our common stock as reported on the New York Stock Exchange — Composite Index during the periods indicated.
The stock prices below have been revised to reflect a three-for-two stock split effected on August 3, 2005.
## Table 1 ##
Holders As of April 24, 2006, there were 2,632 holders of record of Best Buy common stock.
Dividends In fiscal 2004, our Board initiated the payment of a regular quarterly cash dividend, then $0.07 per common share per quarter.
A quarterly cash dividend has been paid in each subsequent quarter.
Effective with the quarterly cash dividend paid in the third quarter of fiscal 2005, we increased our quarterly cash dividend per common share by 10 percent.
Effective with the quarterly cash dividend paid in the third quarter of fiscal 2006, we increased our quarterly cash dividend per common share by 9 percent to $0.08 per common share per quarter.
The payment of cash dividends is subject to customary legal and contractual restrictions.
Future dividend payments will depend on the Company’s earnings, capital requirements, financial condition and other factors considered relevant by our Board.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers In April 2005, our Board authorized a $1.5 billion share repurchase program.
The program, which became effective on April 27, 2005, terminated and replaced a $500 million share repurchase program authorized by our Board in June 2004.
Effective on June 24, 2004, our Board authorized the $500 million share repurchase program, which terminated and replaced a $400 million share repurchase program authorized by our Board in fiscal 2000.
During the fourth quarter of fiscal 2006, we purchased and retired 7.1 million shares at a cost of $338 million.
Since the inception of the $1.5 billion share repurchase program in fiscal 2006, we purchased and retired 16.5 million shares at a cost of $711 million.
We consider several factors in determining when to make share repurchases including, among other things, our cash needs and the market price of the stock.
At the end of fiscal 2006, $790 million of the $1.5 billion originally authorized by our Board was available for future share repurchases.
Cash provided by future operating activities, available cash and cash equivalents, as well as short-term investments, are the expected sources of funding for the share repurchase program.
Management’s Discussion and Analysis of Financial Condition and Results of Operations – Continued Con Edison’s principal business segments are CECONY’s regulated utility activities, O&R’s regulated utility activities and Con Edison’s competitive energy businesses.
CECONY’s principal business segments are its regulated electric, gas and steam utility activities.
A discussion of the results of operations by principal business segment for the years ended December 31, 2014, 2013 and 2012 follows.
For additional business segment financial information, see Note N to the financial statements in Item 8.
Year Ended December 31, 2014 Compared with Year Ended December 31, 2013 The Companies’ results of operations in 2014 compared with 2013 were:
## Table 2 ##
(a) Includes parent company and consolidation adjustments.
(b) Represents the consolidated financial results of Con Edison and its businesses.
## Table 3 ##
reasonably possible that such matters will be resolved in the next twelve months, but we do not anticipate that the resolution of these matters would result in any material impact on our results of operations or financial position.
Foreign jurisdictions have statutes of limitations generally ranging from 3 to 5 years.
Years still open to examination by foreign tax authorities in major jurisdictions include Australia (2003 onward), Canada (2002 onward), France (2006 onward), Germany (2005 onward), Italy (2005 onward), Japan (2002 onward), Puerto Rico (2005 onward), Singapore (2003 onward), Switzerland (2006 onward) and the United Kingdom (2006 onward).
Our tax returns are currently under examination in various foreign jurisdictions.
The most significant foreign tax jurisdiction under examination is the United Kingdom.
It is reasonably possible that such audits will be resolved in the next twelve months, but we do not anticipate that the resolution of these audits would result in any material impact on our results of operations or financial position.13.
CAPITAL STOCK AND EARNINGS PER SHARE We are authorized to issue 250 million shares of preferred stock, none of which were issued or outstanding as of December 31, 2008.
The numerator for both basic and diluted earnings per share is net earnings available to common stockholders.
The denominator for basic earnings per share is the weighted average number of common shares outstanding during the period.
The denominator for diluted earnings per share is weighted average shares outstanding adjusted for the effect of dilutive stock options and other equity awards.
The following is a reconciliation of weighted average shares for the basic and diluted share computations for the years ending December 31 (in millions):
## Table 4 ##
For the year ended December 31, 2008, an average of 11.2 million options to purchase shares of common stock were not included in the computation of diluted earnings per share as the exercise prices of these options were greater than the average market price of the common stock.
For the years ended December 31, 2007 and 2006, an average of 3.1 million and 7.6 million options, respectively, were not included.
During 2008, we repurchased approximately 10.8 million shares of our common stock at an average price of $68.72 per share for a total cash outlay of $737.0 million, including commissions.
In April 2008, we announced that our Board of Directors authorized a $1.25 billion share repurchase program which expires December 31, 2009.
Approximately $1.13 billion remains authorized under this plan.14.
SEGMENT DATA We design, develop, manufacture and market orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products which include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation.
We also provide other healthcare-related services.
Revenue related to these services currently represents less than 1 percent of our total net sales.
We manage operations through three major geographic segments – the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised primarily of Japan and includes other Asian and Pacific markets.
This structure is the basis for our reportable segment information discussed below.
Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based compensation expense, settlement, certain claims, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense.
Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U. S.  and Puerto Rico-based manufacturing operations and logistics.
Intercompany transactions have been eliminated from segment operating profit.
Management reviews accounts receivable, inventory, property, plant and equipment, goodwill and intangible assets by reportable segment exclusive of U.
S and Puerto Rico-based manufacturing operations and logistics and corporate assets.

['

March 31, 2009
Number of Shares (in thousands)	Grant Date Fair Value
Restricted stock awards at March 31, 2008	54	$11.52
Granted	666	16.75
Vested	-167	14.65
Forfeited	-73	17.53
Restricted stock awards at March 31, 2009	480	$16.77

', '

Sales Price
High	Low
Fiscal 2006
First Quarter	$36.99	$31.93
Second Quarter	53.17	36.20
Third Quarter	50.88	40.40
Fourth Quarter	56.00	42.75
Fiscal 2005
First Quarter	$37.50	$30.10
Second Quarter	36.42	29.25
Third Quarter	41.47	30.57
Fourth Quarter	40.48	33.91

', '

CECONY	O&R	Competitive Energy Businesses	Other(a)	Con Edison(b)
(Millions of Dollars)	Increases (Decreases) Amount	Increases (Decreases) Percent	Increases (Decreases) Amount	Increases (Decreases) Percent	Increases (Decreases) Amount	Increases (Decreases) Percent	Increases (Decreases) Amount	Increases (Decreases) Percent	Increases (Decreases) Amount	Increases (Decreases) Percent
Operating revenues	$356	3.4%	$59	7.1%	$148	13.5%	$2	40.0%	$565	4.6%
Purchased power	70	3.5	21	9.7	227	26.4	-	-	318	10.3
Fuel	-35	-10.9	-	-	-	-	-	-	-35	-10.9
Gas purchased for resale	77	14.5	12	15.8	88	Large	-1	Large	176	27.7
Other operations and maintenance	138	5.0	16	5.3	3	2.9	-	-	157	5.0
Depreciation and amortization	45	4.8	5	8.9	-4	-17.4	1	Large	47	4.6
Taxes, other than income taxes	-18	-1.0	-2	-3.2	2	11.8	-	-	-18	-0.9
Gain on sale of solar electric production projects	-	-	-	-	45	-	-	-	45	-
Operating income (loss)	79	3.8	7	5.8	-123	Large	2	Large	-35	-1.6
Other income less deductions	10	Large	2	Large	20	Large	-3	Large	29	Large
Net interest expense	16	3.1	-2	-5.4	-143	Large	1	3.8	-128	-17.8
Income before income tax expense	73	4.7	11	13.1	40	62.5	-2	-9.1	122	7.9
Income tax expense	35	6.7	16	84.2	34	82.9	7	31.8	92	19.3
Net income for common stock	$38	3.7%	$-5	-7.7%	$6	26.1%	$-9	Large	$30	2.8%

', '

Twelve Months Ended December 31, 2014	Twelve Months Ended December 31, 2013
(Millions of Dollars)	Electric	Gas	Steam	2014 Total	Electric	Gas	Steam	2013 Total	2014-2013 Variation
Operating revenues	$8,437	$1,721	$628	$10,786	$8,131	$1,616	$683	$10,430	$356
Purchased power	2,036	-	55	2,091	1,974	-	47	2,021	70
Fuel	180	-	105	285	174	-	146	320	-35
Gas purchased for resale	-	609	-	609	-	532	-	532	77
Other operations and maintenance	2,270	418	185	2,873	2,180	351	204	2,735	138
Depreciation and amortization	781	132	78	991	749	130	67	946	45
Taxes, other than income taxes	1,458	248	92	1,798	1,459	241	116	1,816	-18
Operating income	$1,712	$314	$113	$2,139	$1,595	$362	$103	$2,060	$79

', '

2008	2007	2006
Weighted average shares outstanding for basic net earnings per share	227.3	235.5	243.0
Effect of dilutive stock options and other equity awards	1.0	2.0	2.4
Weighted average shares outstanding for diluted net earnings per share	228.3	237.5	245.4

']

Question: % ( % ) change of the dilutive effect from 2006-2008
Answer: 0.58333